Related Experiment Video
Updated: May 2, 2026

Percutaneous Hepatic Perfusion PHP with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver
Published on: July 31, 2016
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic
Majid A Almadi1, Alan Barkun, James Brophy
1Division of Gastroenterology, Department of Medicine, King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia.
Upper gastrointestinal bleeding is common, especially in patients on antiplatelet or anticoagulant drugs. Management focuses on restarting therapy safely and preventing recurrence, considering drug interactions.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Upper gastrointestinal (GI) bleeding is a frequent medical issue with significant mortality.
- Risk factors include antiplatelet (e.g., aspirin, clopidogrel) and anticoagulant (e.g., warfarin) medications.
Observation:
- A case study of an 86-year-old woman with nonvariceal upper GI bleeding on antiplatelet/anticoagulant therapy is presented.
- Recurrence rates for bleeding can be high, influenced by age, sex, and NSAID use.
Findings:
- The study addresses the critical management of GI bleeding in patients on antithrombotic therapy.
- Key considerations include optimal timing for restarting antiplatelet/anticoagulant therapy and minimizing bleeding recurrence.
- Potential drug interactions, such as between clopidogrel and proton pump inhibitors, are discussed.
Implications:
- Effective management strategies are crucial for improving outcomes in patients with GI bleeding on antithrombotic therapy.
- Understanding recurrence risks and drug interactions informs clinical decision-making for safe and effective treatment.
- This case highlights the need for personalized management plans for elderly patients with complex medication regimens.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Pharmaceutical Poisoning: Treatment Strategies
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management

